Understanding and attacking the circadian rhythm of cancer cells may be the most effective way to treat cancers such as acute myeloid leukemia, according to a new study. Treating cancers such as acute myeloid leukemia is one of the greatest challenges in modern medicine. Because cancer cells are human cells, many therapies that target cancer […]
Comprender y atacar el ritmo circadiano de las células cancerosas puede ser la forma más eficaz de tratar cánceres como la leucemia mieloide aguda, según un nuevo estudio. Tratar cánceres como la leucemia mieloide aguda es uno de los mayores retos de la medicina moderna. Dado que las células cancerosas son células humanas, muchas terapias […]
A new study has identified the gene that may be the missing link between sleep deprivation and metabolic disorders. Scientists have long known that there is a link between poor sleep and disorders of the metabolic system such as obesity and type 2 diabetes. Studies have indicated that some people are more susceptible to the endocrine-crushing effects […]
Un nuevo estudio ha identificado el gen que podría ser el eslabón perdido entre la falta de sueño y los trastornos metabólicos. Los científicos saben desde hace tiempo que existe una relación entre la falta de sueño y trastornos del sistema me tabólico como la obesidad y la diabetes de tipo 2. Los estudios indican […]
Melatonin has been proven to affect sleep-wake patterns, cell growth and a variety of cell pathways. New studies indicate it may control female fertility as well. Our bodies run on a variety of rhythms, including a 24-hour circadian rhythm and a seasonal rhythm. Women’s bodies also have a monthly cycle that governs female fertility. New […]
Many students have difficulty falling asleep early, which makes getting up for early class... [Read More][weiterlesen]
A new study by researchers at the University of Surrey, the University of South Carolina, ... [Read More][weiterlesen]
A research team led by scientists from several Japanese institutions has identified a comp... [Read More][weiterlesen]
